PRA Health Sciences, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
PRA Health Sciences, Inc. | PRAH - NASDAQ |
$20.00-$23.00 |
$18.00 |
$18.55 | 16.98 million | 11/13/2014 |
Jefferies, Citigroup, KKR, UBS Investment Bank, Credit Suisse, Wells Fargo Securities
|
Co-Manager(s): Baird, William Blair |
Health Care |
Filing(s): Filed 2014-09-08 Terms Added 2014-11-03
|
For IPO Boutique's "scale of 1 to 5" BUY rating on PRA Health Sciences, Inc., and our comprehensive analysis, click "Buy Market Research".
PRA Health Sciences, Inc. Quote & Chart - Click for current quote -
PRAH
About PRA Health Sciences, Inc. (adapted from PRA Health Sciences, Inc. prospectus):
They are one of the worlds leading global contract research organizations, or CROs, by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries.
This description is adapted from PRA Health Sciences, Inc. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as PRA Health Sciences, Inc. "PRAH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved